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SUMMARY 
In a clinically monitored surveillance of adverse drug reactions in a sample of 186 indoor patients in 
a general hispital over an average hospital stiy of about two weeks, the following points were noteworthy. 
32.8% of the patients reported side-effects and of these 79.3% were of mild to moderate intensity. 
Side-effects could be easily managed by specific antidotes and reassurance and permitted continuation 
of the same medication, 
There was no association between side-effects and socio-demography or clinical characteristics of 
the patient. Side-effects fitted in with the pharm icological profiles of the drugs used. In only 7.3% of 
cases was ra ijor treatment change made after the occurence of the side effect. Improvement was independent 
of side-effects and no unusual or tcxic reactions were seen. 
Drug surveillance is defined as a sys-
tematic recording of drug administration 
and the experience of patients who have 
received specific drugs. The information 
deduced from such a surveillance would be 
of great value to the physician and his 
patients. Analysis of data would yield 
ample information about pharmacological 
agents in clinical practice (Michel and 
KoJakowska, 1981; Prien et al., 1978; 
Clarks & delGuidice, 1970). It would also 
reveal patterns of prescribing, varying sus-
ceptibility of symptoms to pharmacothe-
rapy and attitude of both patients and 
physician to drug treatment. It would 
reveal the incidence, type and intensity of 
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adverse reactions, their acceptance by both 
doctors and patients and their treatment. 
AIMS 
A prospective total Drug Surveillance 
project in psychiatry in patients admitted 
at our unit in K. E. M. Hospital was 
undertaken as a joint project between the 
department of psychiatry and the clinical 
Pharmacology Unit in order to investi-
gate the adverse reactions to psychotropic 
drugs. We followed, for the purpose of 
this study, the definition of an adverse rea-
ction of a drug as one which is noxious, is 
unintended and occurs atdosages normally 
used in man. All side-effects come with-
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in the scope of this definition and for the 
purpose of this paper side-effects and ad-
verse reactions have been used synonym-
ously. 
The aim of the present study was to 
evaluate the effects of psychotropic drugs 
in terms of side-effects and their assbcia-
tion with 1) sociodemography 2) clinical 
characteristics of the patient 3) pharmaco-
logical profile of the drug and 4) the atti-
tude of the patient and the physician to-
wards the side effect. 
MATERIAL AND METHODS 
A randomised sample constituting 
33% of the total indoor patient popula-
tion of our unit was kept under survei-
llance for one year. The proforma 
for recording the data was evolved 
through joint consultations between the 
psychiatrists, the clinical pharmacologists 
and the statistician. 
The details of the proforma was en-
tered directly in code numbers which 
could be readily transferred to punch-
cards designed for computer analysis. 
Each proforma represented a detailed 
record of all drugs administered, their 
dose, frequency, reasons for starting the-
rapy, reasons for stopping or altering the 
dose, duration of drug administration, out-
come of treatment aid outcome of adverse 
reactions. Adverse drug reactions (ADR) 
were studied in detail to establish their re-
lationship to drugs administered, their 
mechanisms, outcome, effect and antidote. 
The International Classification of 
Diseases 9th revision (1975) was used. 
Provision was made for one principal and 
two additional diagnoses. A comprchen 
sive 3 digit code was used for recording 
physical signs and symptoms. A social 
rating scale giving equal wcightage to 
education, occupation and per capita in-
come was used for determining the social 
status. The symptom check-iijt was ad-
ministered every fifth day and on the 
day of discharge. A 3 digit code was 
used to record all possible ADRs. The 
day the reaction began, the day it subsi-
ded, its severity and any change in treat-
ment were noted. Provision was made 
in the proforma to record 3 ADRs. occu-
rring simultaneously. 
A weekly meeting of the clinical 
pharmacologist, the psychiatrist and sta-
tistician was held to comment upon the 
nature of the ADR and to supervise the 
recording of the proformas by the house 
physicians. 
The house physicians recorded the 
data daily with a periodic symptom asse-
ssment. It was found that patients did 
not report milder side-effects and so a 
list of thirteen questions was prepared 
pertaining to the known side-effects of 
dryness of mouth, constipation, difficulty 
in micturition, blunirg of vision, giddi-
ness, drowsiness, tremulousr.css, diplopia, 
nasal congestion, loss of appstitc, restless-
ness, insomnia and muscle spasms. 
186 patients were included in the 
study and then the data was subjected to 
statistical analysis. The chi-squarc test, 
the 't' test the 'z' test and correlation 
coefficient analyses were the statistical 
methods used to find out the relation-
ships between the different variables. 
Computer-assisted tabulations were made 
by the statistician and interpretation was 
done by the clinicians. Laboratory in-
vestigations were not done routinely but 
only when indicated by the patient's cli-
nical condition. 
RESULTS A.ND DISCUSSIOM : 
Socio-ditnographic variables : 
The group of patients developing 
adverse reactions (SEG) (side effects gro-
up) comprising of 61 patients did not 
differ significantly from the total group 
(ALLG) of 186 patients in any socio-demo-
graphic variable. The average age of SEG 
was 34.8 years with standard deviation of 
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was 31.9 years with standard deviation of 
12.7 yrs. The average SEG height was 
166 cms with s. d. 8.2 and ALLG had an 
average height of 165 cms with s. d. of 
8.30. 85.5% of the ALLG were urban 
based as against 84.1% of the SEG, which 
is in agreement with the drainage area of 
this city liospital. The mean weight of 
the ALLG was only 49 kg as against the 
mean weight of 56 kg. in the SEG but 
this too did not attain significance. 68.8% 
of the ALLG were male, as compared to 
68.3% in the SEG. With respect to 
per capita h come ai d educational achie-
vements also the two groups did not show 
any significant differences. 
Prescription pAUrn : 
The most commonly employed psy-
chotropic agents were Chlorpromazine 
(23.5%), Trifluperazine (9.8%), Imipra-
mine, ;23.2%), chlordiazepoxide (6.1%) 
and chloral hydrate (20.4%) which was 
used as a hypnotic. This prescription 
pattern is in tune with the drugs available 
on the hospital schedule. Such a restric-
ted prescription pattern in a free public 
hospital does not allow comparison of 
various drugs but since several patients 
receive the same medication their res-
ponses can be compared and patient 
variables can be defined. This is in sharp 
contrast to Leckrnari et al's (1977) report « 
where 10 different neuroleptics as aga-
inst two in this study, 5 different antide-
pressants against one, four different anxi-
olytics against one in our study and 3 
different anti-parkinsonian agents against 
one in our hospital, have been employed. 
As reported by Michel and Kolakowska 
(198!), Diamond et al (1976), Hemminki 
(1977) and Prien et al (1978), polyphar-
macy with psychotherapeutic agents is 
quite common but in our hospital, be-
cause of n on -availability of different varie-
ties of drugs the prescriptions are more 
concise. On an average each patient 
received only 3.4 drugs throughout his 
hospital stay and the side effect group 
received 3.8 drugs on an average. This 
marginal non-significant difference is at-
tributable to the use of antiparkinsonian 
agents like Trihexiphenidyl 2 mg. tablets 
and hjectable Promethazine hydrochl-
oride and Bitacodyl for the treatment of 
emergen t symp roms. 
The maximum dose received by each 
patient rar.ged from 400-1200mg daily 
of Chlorpromazine, 15-45 mg daily of Tri-
fluperazine, 150-300 mg of Imipramine, 
1 gm-2 gms of chloral hydrate and 60-90 
mg of Chlordiazepoxide. In 68 out of 
82 in tan ccs of side-effects, chlorpromazine 
(36), Imipramine (19), Trifluperazine (8) 
and chlordiazepoxide (5) were implicated. 
Incidv.ce of Adverse Drug Reaction 
As shown in Table I 61 out of 186 
patients under surveillance reported 82 
instances of side effects. Thus 32.8% of 
patients developed on an average 1.34 
TABLE 1. Adverse Reactions 
Type Frequency 
1. Drowsiness 1" 
2. Constipation 15 
3. Giddiness, Postural Hypotension 21 
4. Dryness of mouth H 
5. Parkinsonian Reaction 6 
6. Dystonia 2 
7. Akathisia ' 
8. Diarrhoea 2 
9. -.Loss of Appetite I 
10. Difficulty in Micturition 4 
11. Hyperpyrexia ' 
12. Confusion—Disorientation 1 
13. Drug Rash 1 
Total 82 232  L. P. SHAH et al. 
side effects each. In our study patients 
were interrogated daily regarding the 
commoner side effects using a side effects 
check list of 13 questions and so we were 
able to tap the milder side-effects. Leck-
man et al. (1977) report an incidence of 
9.3% only in 5630 patients, but the me-
thodology is totally different from what we 
have employed. Wade (1970) has cal-
culated the incidence of adverse reactions 
per million prescriptions which yielded 
very low results of 20.7, 26.0 and 9.8 non-
fatal adverse reactions per million presc-
riptions for phenothiazines, tricyclics and 
benzodiazepines respectively. Reports on 
outpatient populations suffer because of 
uncertain compliance. Mental hospital 
surveys include a disproportionate number 
of long stay patients chronically on medi-
cation and therefore yield results which 
are not comparable to ours. 
In a general hospital with a mean hos-
pital stay of 13.8 days, incidence of ADRS 
of 32.8% with the restricted drugs availa-
ble for use, in our opinion, is acceptable. 
Type of Adverse Drug Reaction 
As seen in Table I all the side-effects 
were well known and common (Ban, 1969, 
TABLE II 
No. of side-effects No. of'p.-.tients Percentage 
1 46 75.4 
2 8 1S.1 
3 7 11.5 
Toll 61 100.0 
Severity ofsidc- No.ofside- Percentage 
effet ts effet ts 
Mild 30 36.6 
Moderate 35 42.7 
Severe 13 18.3 
Extremely severe 2 2.4 
Tot. I 82 100.0 
Martin, 1971, Kelin & Davis, 1969; 
Jarvik, 1977; Shader and DiMascio, 1970) 
there were no toxic reactions or intoxica-
tion due to overdosage. No unusual reac-
tions were seen. One case of confusion -
disorientation was due to the additive 
anticholinergic effects of phenothiazines 
and antiparkinsonian drugs. Imipramine 
was responsible for the drug rash, this was 
confirmed and treated by withdrawing im-
ipramine and starting antihistaminics. 
Number and Severity of Adverse Drug Reaction 
As shown in Table II, 7 patients 
developed 3 ADRs. The common com-
bination was constipation, dryness of 
mouth and giddiness in patients recei-
ving between 150-225 mgm of Imipra-
mine daily. 79% of side effects were 
mild or moderate in intensity. In only 
2 instances of acute dystonia could the 
adverse reaction be labelled as extremely 
severe. 
Altitude towards the adverse drug nitc'i's.-* 
[ADR) 
As shown in Table III, 95.2% of 
the side effects were 'expected' being 
TABLE III Attitudes towards adverse reaction 
of drugs 
N=82 % 
A. Expected 78 95.2 
Unexpected 2 2.4 
Cannot S.'.y 2 2.4 
B. Accepted by PhysicLn 70 85.4 
Not Accepted by Physici.n 10 12.2 
Cannot say whcthei Accep-
ted or not 2 2.4 
C. Accepted by Patient 39 47.6 
Not Accepted by Patient 32 39.0 
Cannot say whether Accep-
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known to be part of the pharmacologi-
cal profile of the drug at the prescribed 
dosage. In two instances-drug rash and 
confusion-disorientation-the side effect 
was unexpected. In two instances of 
diarrhoea the symptom was treatment-
emergent and since no cause could be 
found through laboratory investigadons, 
it could not be said whether the reaction, 
was expected or other wise. In our opin-
ion the symptom was not drug-related. 
In these same two cases it could not be 
decided whether the reaction was accep-
table to the physician, but empirically, 
treatment with binding mixture was 
instituted. 
In 84.4% the ADR was acceptable 
to the physician. In 10 instances the side 
effect was not accepted and treatment 
was modified accordingly. 
The mild side effects as mentioned 
earlier were elicited on specific enquiry 
only and were accepted by the patient. 
In 11 instances it was not possible to judge 
the patient's acceptance because of their 
disturbed mental status at the time when 
the ADR occurred. Reassurances by 
the physician was sufficient in most pati-
ents to make them accept the side-effe-
cts and permit continuation of the same 
medication. 
Treatment of adverse drug reaction (Table IV) 
In 41.5% of ADRs no change was 
made because of acceptance by both 
TABLE IV Treatment of adverse reactions 
(N—82) 
Drug Stopped 
Dose Decreased 
Alternative Treatment 
No Change 
Antidote Added 
N 
5 
15 
1 
34 
27 
82 
% 
6.1 
18.3 
1.2 
41.5 
32.9 
100.0 
physician and patient. In 18.3% the 
only change was reduction in drug dosage. 
Antidotes-Bisacodyl for constipation and 
trihexiphenidyl and injection Prometha-
zine HC1 for extra pyramidal symptoms 
were added in 32.9% of ADRs. Alter-
native treatment with EGT was begun 
in the patient developing drug rash with 
imipramine. The offending drug was 
stopped in only 5 out of 82 instances of 
ADRs. Thus in only 7.3% (6.1 + 1.2) 
of the ADRs was the treatment modified 
significantly. 
Certain clinical variables and adverse effects : 
The side-effect group (SEG 61 pati-
ents) stayed slightly longer (mean 15 
days with s.d. of 9.4 days) in the hospi-
tal as compared to those without side 
effects (125 patients, mean 13 days, s.d. 
8.8 days). The 186 patients in our study 
initially reported 6.8 symptoms on an 
average as against 7.42 symptoms reported 
by SEG. 
92.8% of 186 patients had improved 
markedly at the time of discharge and 
only 2.2% showed no improvement. The 
occurence or otherwise of ADRs made no 
difference in this respect. This also shows 
that short-term hospitalization and treat-
ment are effective measures for this parti-
cular patient group. 
The value of a study like the present 
one in leading to a drug audit and a mini-
mum pharmacopoeia would be great 
but at our institution, as it is, perhaps 
out of necessity, we practice a minimum 
pharmacopoeia. To detect unusual 
ADRs a much larger sample consisting 
of patients from several different centres 
engaged in collaborative research will 
be required. ADR occuring after pro-
longed exposure to the drugs would 
require long term follow through studies. 
Facilities for monitoring drug treatment 
by routine instrumentation being lac-
king at our centre, it was not done, but 
future surveillance studies must aim at 2:n  L. P. SHAH et al. 
correlating ADRs with biochemical inve-
stigations which will also serve as mea-
sures of patient compliance. 
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